Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for QA Review of In-Process Control Records – V 2.0

Posted on By

API Manufacturing: SOP for QA Review of In-Process Control Records – V 2.0

Standard Operating Procedure for QA Review of In-Process Control Records in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/176/2025
Supersedes SOP/API/176/2022
Page No. Page 1 of 13
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define a systematic procedure for Quality Assurance (QA) review of In-Process Control (IPC) records generated during API manufacturing to ensure documentation accuracy, adherence to GMP, and verification of process compliance.

2. Scope

This SOP is applicable to all IPC records generated during the manufacturing of APIs including those related to raw material

verification, reaction monitoring, intermediate testing, filtration checks, drying confirmation, and milling or blending operations at the API manufacturing site.

3. Responsibilities

  • Production/Process Chemists: Record all IPC data in approved formats and submit records for QA review.
  • QA Officer/Executive: Reviews IPC records for completeness, accuracy, GMP compliance, and any discrepancies.
  • QC Department: Provides analytical results for IPC sampling performed in the lab, if applicable.
  • QA Documentation Cell: Maintains reviewed IPC records and tracks observations or trending data.
See also  API Manufacturing: SOP for Documentation and Yield Calculation for Solvent Recovery - V 2.0

4. Accountability

The Head of QA is accountable for ensuring the integrity, traceability, and compliance of IPC records through timely and effective QA review processes.

5. Procedure

5.1 Types of IPC Records Reviewed

  1. IPC records include:
    • pH checks during reaction stages
    • Moisture content during drying (LOD)
    • Filtration clarity and filter integrity
    • Intermediate identification and assay (TLC/HPLC)
    • Temperature or pressure logs
    • Sampling logs and retention samples

5.2 Record Collection and Submission

  1. Production personnel must submit completed IPC records to QA daily or at stage completion.
  2. All entries must be:
    • Legible, with black or blue ink
    • Initialed and dated by the performer
    • Crossed out with a single line in case of correction (no overwriting)
  3. QA shall reject any record not complying with ALCOA+ principles.

5.3 QA Review Checklist

  1. QA shall verify:
    • Correct batch number and stage name
    • Authorized signatory and date/time of activity
    • Limits/specifications as per BMR/BPR
    • Any deviation or OOT noted and escalated
  2. Use IPC Record Review Checklist (Annexure-1).
  3. If discrepancies are observed, a QA Observation Form shall be raised (Annexure-2).
See also  API Manufacturing: SOP for Approval of Analytical Methods and Specifications - V 2.0

5.4 Approval and Documentation

  1. If records are found compliant, QA shall sign and date each page with a “Reviewed by QA” stamp.
  2. Records shall be filed in the respective batch file maintained in QA archives.
  3. Any analytical values received from QC shall be reconciled with production records before QA approval.

5.5 Trending and Monitoring

  1. QA shall maintain a Monthly IPC Record Tracker (Annexure-3) to trend:
    • Number of IPCs reviewed
    • Non-compliance observed
    • Repeat observations across batches
  2. This trending shall be used in the APQR and for planning training needs.

5.6 Deviations and Investigation

  1. In case of critical or recurring documentation errors, QA shall initiate a deviation and conduct root cause analysis.
  2. Based on impact, retraining or CAPA may be initiated.

6. Abbreviations

  • IPC: In-Process Control
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • OOT: Out of Trend
  • CAPA: Corrective and Preventive Action
  • ALCOA+: Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available

7. Documents

  1. IPC Record Review Checklist (Annexure-1)
  2. QA Observation Form (Annexure-2)
  3. Monthly IPC Record Tracker (Annexure-3)
See also  API Manufacturing: SOP for Conductivity Measurement in Process Solutions - V 2.0

8. References

  • ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – Subpart F: Production and Process Controls
  • EU GMP Guidelines – Part II

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IPC Record Review Checklist

Checkpoint Compliant (Y/N) Comments
Batch Number matches BMR Y –
Signatures & Date present Y –
Limits followed Y –

Annexure-2: QA Observation Form

Observation No. Date Observed By Description Action Taken
QA/OBS/2025/04 12/04/2025 Sunita Reddy Missing IPC limits on pH record Clarified and retrained

Annexure-3: Monthly IPC Record Tracker

Month Total IPCs Reviewed Observations Raised Repeat Issues
March 2025 48 3 1

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP New document QA Head
14/04/2025 2.0 Added IPC tracker, observation form Improved traceability QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: Zeta Potential Determination SOP – V 2.0
Next Post: Gel Manufacturing: SOP for In-Process pH Adjustment of Gels – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version